Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

HemoCleanse submits 510(k) for ThermoChem-HT

Aug. 7, 1997

New agent for breast cancer in development at Zenyaku Kogyo

Aug. 7, 1997

Antiproliferative agents from Kirin Brewery

Aug. 6, 1997

Korean researchers isolate aminopeptidase inhibitors from microbial source

Aug. 6, 1997

Novel camptothecin analogues reported by Korean scientists

Aug. 6, 1997

KSA-based cancer vaccine in development

Aug. 5, 1997

Seven more marketing approvals announced for Campto

Aug. 4, 1997

Apoptosis Technology and BioChem Pharma to collaborate on anticancer agents

Aug. 4, 1997

Janssen reports farnesyl protein transferase inhibitors

Aug. 4, 1997

Nutraceutix in-licenses breast cancer preventive agent

Aug. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...